CINECA IRIS Institutional Research Information System

VOLANTE, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.015
EU - Europa 11.205
AS - Asia 8.307
SA - Sud America 956
OC - Oceania 246
AF - Africa 204
Continente sconosciuto - Info sul continente non disponibili 23
Totale 38.956
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.526
CN - Cina 3.360
IT - Italia 2.814
SG - Singapore 1.801
DE - Germania 1.210
IE - Irlanda 983
FR - Francia 973
SE - Svezia 825
JP - Giappone 659
BR - Brasile 639
UA - Ucraina 611
FI - Finlandia 590
GB - Regno Unito 566
IN - India 529
KR - Corea 509
AT - Austria 422
PL - Polonia 391
ES - Italia 356
CA - Canada 337
VN - Vietnam 323
TR - Turchia 299
NL - Olanda 252
AU - Australia 220
RU - Federazione Russa 167
GR - Grecia 159
ID - Indonesia 152
HK - Hong Kong 147
DK - Danimarca 145
MX - Messico 133
AR - Argentina 131
BE - Belgio 130
CH - Svizzera 101
TW - Taiwan 100
SN - Senegal 89
PT - Portogallo 88
RO - Romania 86
HU - Ungheria 84
CO - Colombia 69
TH - Thailandia 66
CZ - Repubblica Ceca 58
IL - Israele 57
CL - Cile 56
SA - Arabia Saudita 52
MY - Malesia 48
NO - Norvegia 37
PH - Filippine 36
DZ - Algeria 33
EC - Ecuador 31
UZ - Uzbekistan 31
HR - Croazia 28
RS - Serbia 28
PK - Pakistan 26
NZ - Nuova Zelanda 24
SI - Slovenia 23
EU - Europa 22
EG - Egitto 20
LT - Lituania 15
PE - Perù 15
ZA - Sudafrica 15
BA - Bosnia-Erzegovina 12
IQ - Iraq 12
SK - Slovacchia (Repubblica Slovacca) 12
AE - Emirati Arabi Uniti 11
IR - Iran 11
JO - Giordania 11
BG - Bulgaria 9
BD - Bangladesh 8
BY - Bielorussia 8
MA - Marocco 8
VE - Venezuela 8
AM - Armenia 7
EE - Estonia 7
KE - Kenya 7
QA - Qatar 7
KZ - Kazakistan 6
NG - Nigeria 6
SD - Sudan 6
AZ - Azerbaigian 5
LB - Libano 5
MK - Macedonia 5
PR - Porto Rico 5
OM - Oman 4
TN - Tunisia 4
UY - Uruguay 4
CY - Cipro 3
MO - Macao, regione amministrativa speciale della Cina 3
MT - Malta 3
MU - Mauritius 3
NP - Nepal 3
PA - Panama 3
SC - Seychelles 3
SY - Repubblica araba siriana 3
TG - Togo 3
BO - Bolivia 2
CU - Cuba 2
FJ - Figi 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
KG - Kirghizistan 2
Totale 38.926
Salva come PNG Salva come JPEG
Città #
Chandler 1.558
Beijing 1.453
Houston 1.136
Fairfield 1.101
Santa Clara 1.096
Singapore 991
Dublin 963
Ashburn 784
Ann Arbor 705
Redwood City 659
Torino 578
Wilmington 574
Woodbridge 568
Seattle 487
Villeurbanne 402
Jacksonville 376
Cambridge 368
Vienna 349
Nyköping 335
Pisa 334
Medford 300
Princeton 300
Dearborn 289
Columbus 283
Warsaw 271
Turin 220
Shanghai 196
Milan 193
Guangzhou 180
Dong Ket 173
Boston 159
Tokyo 159
New York 146
Fremont 136
Jakarta 136
Nanjing 131
Hangzhou 106
Helsinki 104
Boardman 102
Munich 99
Würzburg 92
Chicago 90
São Paulo 88
San Diego 87
Pune 80
Chengdu 79
Rome 77
Düsseldorf 76
Los Angeles 75
Toronto 75
Seoul 74
Madrid 68
Paris 66
Athens 64
Brussels 63
Istanbul 62
Shenyang 60
Buenos Aires 59
Hong Kong 58
Hefei 57
Taipei 56
London 54
Norwalk 54
Silver Spring 54
Zhengzhou 53
Bologna 52
Verona 52
Ankara 50
Nuremberg 49
Phoenix 49
Santiago 49
Padova 48
Washington 48
Falls Church 45
Wuhan 45
Budapest 44
Birmingham 43
New Delhi 43
Brescia 42
Pittsburgh 42
Moscow 41
Rochester 40
Florence 39
Amsterdam 38
Changsha 38
Bethesda 37
Kunming 37
Canberra 36
Jinan 36
Barcelona 34
Rio de Janeiro 34
Berlin 33
Mountain View 33
Bogotá 32
Tappahannock 32
Central District 30
Rotterdam 30
Lexington 28
Philadelphia 28
Bangkok 27
Totale 21.605
Salva come PNG Salva come JPEG
Nome #
The weiss score and beyond--histopathology for adrenocortical carcinoma. 1.400
The Reticulin Algorithm for Adrenocortical Tumor Diagnosis: A Multicentric Validation Study on 245 Unpublished Cases. 1.191
Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology 897
Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma 734
Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior. 710
Mixed Adenoneuroendocrine Carcinomas (MANECs) of the Gastrointestinal Tract: Targeted Next Generation Sequencing Suggests a Monoclonal Origin of the Two Components 600
β1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells. 541
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study. 509
IMPACT OF PREGNANCY ON PROGNOSIS OF DIFFERENTIATED THYROID CANCER: CLINICAL AND MOLECULAR FEATURES. 477
Oncocytic Adrenocortical Tumors: Diagnostic Algorithm and Mitochondrial DNA Profile in 27 Cases. 461
Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma. 451
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. 450
Tumor staging but not grading is associated with adverse clinical outcome in neuroendocrine tumors of the appendix: a retrospective clinical pathologic analysis of 138 cases. 447
Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart 435
Extrapulmonary neuroendocrine small and large cell carcinomas: a review of controversial diagnostic and therapeutic issues. 404
Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation. 399
Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm 371
RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact 363
MITOTANE LEVELS PREDICT THE OUTCOME OF PATIENTS WITH ADRENOCORTICAL CARCINOMA TREATED ADJUVANTLY FOLLOWING RADICAL RESECTION. 343
Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones 342
microRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations 336
Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification. 336
Functional Role and Prognostic Significance of CD157 in Ovarian Carcinoma 334
Prognostic Role of Overt Hypercortisolism in Completely Operated Patients with Adrenocortical Cancer 329
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. 329
An international Ki67 reproducibility study in adrenal cortical Carcinoma 320
Thymidylate synthase is functionally associated with ZEB1 and contributes to the epithelial-to-mesenchymal transition of cancer cells 310
Therapeutic Biomarkers in Lung Neuroendocrine Neoplasia 306
An exploration of pathways involved in lung carcinoid progression using gene expression profiling 305
Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates 296
Pathology of the Adrenal Cortex: a Reappraisal of the Past 25 Years Focusing on Adrenal Cortical Tumors. 290
Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis 288
Poorly differentiated thyroid carcinoma: 5 years after the 2004 WHO classification of endocrine tumours. 286
Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study. 282
Expression of cortistatin and MrgX2, a specific cortistatin receptor, in human neuroendocrine tissues and related tumours 281
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma 273
RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization 267
MEN1 Gene Mutation and Reduced Expression Are Associated with Poor Prognosis in Pulmonary Carcinoids 259
Differential expression of HER2, STAT3, SOX2, IFI16 and cell cycle markers during HPV-related head and neck carcinogenesis 256
Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases. 256
Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines. 254
Mammalian target of rapamycin pathway activation is associated to RET mutation status in medullary thyroid carcinoma. 253
Updates on lung neuroendocrine neoplasm classification 245
Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma 240
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 234
Retrospective multicenter study investigating the role of targeted next-generation sequencing of selected cancer genes in mucinous adenocarcinoma of the lung 232
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 228
YAP-Dependent AXL Overexpression Mediates Resistance to EGFR Inhibitors in NSCLC 222
mTORC1 Complex is Significantly Over-Activated in SDHX-Mutated Paragangliomas 213
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma 211
Unusual paraneoplastic neurological syndrome secondary to a well differentiated pancreatic neuroendocrine tumor: A case report and review of the literature 210
Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies 209
H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features data from a multi-institutional series 207
Brca1-Associated Protein 1 (BAP1) Immunohistochemical Expression as a Diagnostic Tool in Malignant Pleural Mesothelioma Classification: a Large Retrospective Study 207
CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome. 197
Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lung. 195
Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study 191
Detection and characterization of classical and "uncommon" exon 19 Epidermal Growth Factor Receptor mutations in lung cancer by pyrosequencing 187
Effects of Src kinase inhibition induced by dasatinib in non-small cell lung cancer cell lines treated with cisplatin 183
Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer 181
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study. 176
Increased neuroendocrine cells in resected metastases compared to primary colorectal adenocarcinomas. 174
Bevacizumab Plus Octreotide and Metronomic Capecitabine in Patients with Metastatic Well-to-Moderately Differentiated Neuroendocrine Tumors. The XELBEVOCT Multicenter Phase II Study 173
Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer. 165
RFamide peptides 43RFa and 26RFa both promote survival of pancreatic β-cells and human pancreatic islets but exert opposite effects on insulin secretion. 163
Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide. 160
Biological role and clinical significance of CD157 in epithelial ovarian cancer 152
Mechanical phenotyping of cells and extracellular matrix as grade and stage markers of lung tumor tissues 150
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: A multicenter interobserver variation analysis using virtual microscopy: A Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T) 150
Clinical and biological significance of CD157 in malignant pleural mesothelioma 149
Biological role, clinical significance and potential therapeutic applications of CD157 in ovarian cancer 142
Highly Sulfated K5 Escherichia coli Polysaccharide Derivatives Inhibit Respiratory Syncytial Virus Infectivity in Cell Lines and Human Tracheal-Bronchial Histocultures 139
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer 137
Thymidylate synthase expression in large cell carcinoma ofthe lung 136
PAX8–GLIS3 gene fusion is a pathognomonic genetic alteration of hyalinizing trabecular tumors of the thyroid 135
CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells 134
INHIBITION OF USP7 INDUCES SELECTIVE CANCER CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA THROUGH PTEN AND INDEPENDENTLY FROM P53 STATUS 133
Ribonucleotide Reductase Large Subunit (RRM1) Gene Expression May Predict Efficacy of Adjuvant Mitotane in Adrenocortical Cancer. 132
Tissue arrays as fiducial markers for section alignment in 3-D reconstruction technology 131
CYP2W1 Is Highly Expressed in Adrenal Glands and Is Positively Associated with the Response to Mitotane in Adrenocortical Carcinoma 130
IκBα targeting promotes oxidative stress-dependent cell death 130
Epidermal Growth Factor Receptor Gene in Primary Tumor and Metastatic Sites from Non-small Cell Lung Cancer. J Thorac Oncol. 2009 Apr 29 127
CD157: A New Prognostic and/or Predictive Marker in Ovarian Cancer? A Retrospective Study 126
Differential Thymidylate Synthase Expression in Different Variants of Large-Cell Carcinoma of the Lung 126
Soluble CD157 in pleural effusions: a complementary tool for the diagnosis of malignant mesothelioma 123
Cytology of Primary Salivary Gland-Type Tumors of the Lower Respiratory Tract: Report of 15 Cases and Review of the Literature 122
Caveolin-1 expression in lung carcinoma varies according to tumour histotype and is acquired de novo in brain metastases 122
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 122
CD157 is a novel prognostic marker of malignant pleural mesothelioma involved in the control of tumor aggressiveness 121
Extensive DNA fragmentation in oxyphilic cell lesions of the thyroid. 120
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine 120
Absence of gene mutations in a case of concomitant presence of carcinoid of the ampulla of vater pheochromocytoma and Von Recklinghausen disease 119
Anti-CD38 autoantibodies: characterisation in new-onset type I diabetes and latent autoimmune diabetes of the adult (LADA) and comparison with other islet autoantibodies. 118
99mTc-MIBI Imaging in the presurgical characterization of thyroid follicular neoplasms: relationship to multidrug resistance protein expression 118
Adjuvant mitotane treatment: a prospective experience at the San luigi Hospital, University of Turin, Italy, USA, 2008 117
Clinical and biological significance of CD157 in ovarian carcinoma 117
CD157 CONTROLS PERITONEAL DISSEMINATION AND INVASION OF OVARIAN CARCINOMA AND IS A MOLECULAR PREDICTOR OF POOR CLINICAL OUTCOME 114
Androgen deprivation modulates gene expression profile along prostate cancer progression 114
Integrative analysis of SF-1 transcription factor dosage impact on genome-wide binding and gene expression regulation 113
Ghrh promotes survival of cardiac myocytes in vitro and protects against ischemia-reperfusion injury in rat heart 112
Totale 27.125
Salva come PNG Salva come JPEG
Categoria #
all - tutte 105.170
article - articoli 0
book - libri 0
conference - conferenze 8.737
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.907
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.625 0 0 0 0 0 0 0 0 550 471 330 274
2020/20214.488 366 266 392 259 377 395 445 256 400 409 378 545
2021/20224.330 262 297 252 373 268 237 302 297 190 303 801 748
2022/20235.483 550 449 176 511 475 1.233 403 369 577 186 288 266
2023/20243.279 366 453 227 208 258 428 162 236 35 201 294 411
2024/20255.870 164 554 339 643 1.776 612 408 510 864 0 0 0
Totale 40.073